Multidrug Resistance Protein 4 (MRP4/ABCC4) Protects Cells from the Toxic Effects of Halobenzoquinones

被引:12
|
作者
Li, Jinhua [1 ,2 ]
Bauer, Madlen [1 ]
Moe, Birget [1 ,3 ]
Leslie, Elaine M. [1 ,4 ]
Li, Xing-Fang [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB T6G 2G3, Canada
[2] Jilin Univ, Sch Publ Hlth, Changchun 130021, Jilin, Peoples R China
[3] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Alberta Ctr Toxicol, Calgary, AB T2N 4N1, Canada
[4] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
DISINFECTION BY-PRODUCTS; DRINKING-WATER DISINFECTION; OXIDATIVE STRESS; BROMO-BENZOQUINONES; REDUCED GLUTATHIONE; THIOL REACTIVITY; ELIMINATION; TRANSPORTER; COTRANSPORT; ACIDS;
D O I
10.1021/acs.chemrestox.7b00156
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Halobenzoquinones (HBQs) are frequently detected disinfection byproducts (DBPs) in treated water. Recent studies have demonstrated that HBQs are highly cytotoxic and capable of inducing the generation of reactive oxygen species (ROS) and depleting cellular glutathione (GSH). Multidrug resistance proteins (MRPs/ABCCs) are known to play a critical role in the elimination of numerous drugs, carcinogens, toxicants, and their conjugated metabolites. In general, little is known about the roles of transporters in DBP toxicity. Here, we hypothesize that MRPs may play roles in the detoxication of HBQs. To test this hypothesis, we used human embryonic kidney 293 (HEK293) cells stably expressing MRPs (MRP1, 3, 4, and 5) and HEK293 cells with empty vector (HEK-V) to examine the comparative cytotoxicity of four HBQs: 2,6-dichloro-1,4-benzoquinone (2,6-DCBQ), 2,6-dibromo-1,4-benzoquinone (2,6-DBBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), and 2,3,6-trichloro-1,4-benzoquinone (TriCBQ). The cytotoxicity (IC50) of the four HBQs in HEK-MRP1, -MRP3, -MRP4, and -MRP5 cells and the control HEK-V cells clearly showed that MRP4 had the most significant effect on reducing the toxicity of the four HBQs. To further support MRP4-mediated detoxication of HBQs, we examined the HBQ-induced ROS levels in HEK-MRP4 and HEK-V cells. ROS levels were significantly reduced in HEK-MRP4 cells compared with HEK-V cells after HBQ treatment. Furthermore, it was found that MRP4-mediated detoxication of the HBQs was GSH dependent, as the cytotoxicity of the HBQs was increased in GSH-depleted HEK-MRP4 cells in comparison to HEK-MRP4 cells. The GSH-dependent protection of cells from HBQs supports the possibility of HBQ-GSH conjugate efflux by MRP4. This study demonstrates a role for MRP4 in cellular protection against HBQ DBP-induced toxicity and oxidative stress.
引用
收藏
页码:1815 / 1822
页数:8
相关论文
共 50 条
  • [41] MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
    Belleville-Rolland, Tiphaine
    Sassi, Yassine
    Decouture, Benoit
    Dreano, Elise
    Hulot, Jean-Sebastien
    Gaussem, Pascale
    Bachelot-Loza, Christilla
    PHARMACOLOGICAL RESEARCH, 2016, 107 : 381 - 389
  • [42] Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity
    Wittgen, Hanneke G. M.
    van den Heuvel, Jeroen J. M. W.
    Krieger, Elmar
    Schaftenaar, Gijs
    Russel, Frans G. M.
    Koenderink, Jan B.
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (03) : 366 - 373
  • [43] The multidrug transporter MRP4/ABCC4 is a powerful marker of poor prognosis in neuroblastoma and a target for therapeutic suppression
    Norris, M. D.
    Smith, J.
    Flemming, C.
    Lyn, L.
    Allen, J.
    Cohn, S. L.
    London, W. B.
    Buxton, A.
    Marshhall, G. M.
    Haber, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 121 - 121
  • [44] Regulation of the basal promoter activity of the human MRP4 (ABCC4) transporter
    Kragl, A.
    Ziems, K.
    Glaubitz, J.
    Grammbauer, S.
    Broederdorf, S.
    Cole, S. P. C.
    Tzvetkov, M. V.
    Jedlitschky, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S37 - S37
  • [45] Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney
    Ci, Lei
    Kusuhara, Hiroyuki
    Adachi, Masashi
    Schuetz, John D.
    Takeuchi, Kenji
    Sugiyama, Yuichi
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1591 - 1597
  • [46] A Role For a Multi-Drug Resistance Protein (MRP4/ABCC4) In Pediatric Acute Myeloid Leukemia (AML)
    Lian, Shang Li
    Wang, Yao
    Zhou, Sheng
    Sukthankar, Mugdha
    Neale, Geoffrey A.
    Downing, James R.
    Schuetz, John D.
    BLOOD, 2013, 122 (21)
  • [47] Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
    Adema, Auke D.
    Floor, Karijn
    Smid, Kees
    Honeywell, Richard J.
    Scheffer, George L.
    Jansen, Gerrit
    Peters, Godefridus J.
    SPRINGERPLUS, 2014, 3 : 1 - 11
  • [48] A New Subtype of Human Delta-Storage Pool Deficiency is Associated with a Selective Defect in Platelet Multidrug Resistance Protein 4 (MRP4/ABCC4) Expression
    Jedlitschky, Gabriele
    Cattaneo, Marco
    Lubenow, Lena E.
    Rosskopf, Dieter
    Lecchi, Anna
    Artoni, Andrea
    Motta, Giovanna
    Niessen, Juliana
    Kroemer, Heyo K.
    Greinacher, Andreas
    CIRCULATION, 2008, 118 (18) : S408 - S408
  • [49] Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier
    Kanamitsu, Kayoko
    Kusuhara, Hiroyuki
    Schuetz, John D.
    Takeuchi, Kenji
    Sugiyama, Yuichi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2566 - 2575
  • [50] Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter
    Smeets, PHE
    Van Aubel, RAMH
    Wouterse, AC
    Van Den Heuvel, JJMW
    Russel, FGM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11): : 2828 - 2835